2025
Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review
Duah J, Seifer D. Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review. Reproductive Biology And Endocrinology 2025, 23: 2. PMID: 39762910, PMCID: PMC11702155, DOI: 10.1186/s12958-024-01339-y.Peer-Reviewed Original ResearchConceptsWomen of reproductive ageFDA-approved medicationsGLP1-RAsReproductive ageTotal body weightWeight lossBariatric surgeryPreconception periodBody fat promotes adipose tissue dysfunctionResponse to ovulation inductionCombination of phentermineFirst-line therapyAdvanced maternal ageLive birth rateGLP1 receptor agonistsWeight loss medicationsPoor oocyte qualityRisk of surgeryCombination of naltrexoneSignificant side effectsMetabolic health factorsBody weightSignificant weight lossAnti-obesity drugsNovel pharmacological agents
2007
Relationship of bariatric surgery to Müllerian-inhibiting substance levels
Merhi ZO, Minkoff H, Feldman J, Macura J, Rodriguez C, Seifer DB. Relationship of bariatric surgery to Müllerian-inhibiting substance levels. Fertility And Sterility 2007, 90: 221-224. PMID: 17727846, DOI: 10.1016/j.fertnstert.2007.05.073.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply